Chemed Corp New: (NYSE: CHE)

$67.73

0.04 (0.06%)

Volume 124,470

May 23 04:04 PM ET

Zacks Rank: 4-Sell

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		67.07 - 68.10
	
		52wk Low - High
		54.06 - 82.00
	
		Previous Close
		67.69
	
		Avg. Volume
		551,234
	
		Industry
		MED-OUTP/HM CRE
	
		Market Cap
		1.30 B
	
		Div - Yield
		0.72 - 1.06
	
		Beta
		0.42
	
		PE (Forward)
		13.70
	
		Current Year Est.
		4.94
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		4
Sell

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		206 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/21/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            13.70
                        
                            PEG Ratio
                            1.10
                        
                            Current Year Est.
                            4.94
                        
                            Current Quarter Estimate
                            1.16
                        
                            Most Accurate Estimate
                            1.16
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            07-24-2013
                        
                            EPS Last Year
                            5.23
                        
                            Expected Earnings Growth
                            12.50%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Chemed Corporation is the nation's largest provider of end-of-life hospice care services through its VITAS Healthcare Corporation subsidiary. Chemed also maintains a presence in the residential and commercial repair-and-maintenance industry through two subsidiaries. Roto-Rooter is North America's largest provider of plumbing and drain cleaning services. Service America Network Inc. provides major-appliance and heating/air-conditioning repair, maintenance, and replacement services.   
Full CHE Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
CHE Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	1.16	1.18	4.94	5.28
Number of Estimates	1	1	1	1
Low Estimate	1.16	1.18	4.94	5.28
High Estimate	1.16	1.18	4.94	NA
Year Ago EPS	1.18	1.20	5.04	4.94
EPS Growth	-1.69%	-1.67%	-1.98%	6.88%

More CHE Estimates

Average Earnings Estimates for CHE

EPS Growth for CHE

Industry Analysis

Name	Symbol	Previous Close
CHEMED CORP	CHE	67.69
ADDUS HOMECARE	ADUS	15.91
HEALTHSOUTH CP	HLS	30.19
AMSURG CORP	AMSG	35.85
BRAIN RESOURCE	BRRZY	0.00
CHINA CORD BLD	CO	2.84
DAVITA INC	DVA	126.11
LHC GROUP LLC	LHCG	22.31
QUEST DIAGNOSTC	DGX	61.12
RADNET INC	RDNT	2.49

Sector:Medical>> Industry:MED-OUTP/HM CRE

COMPARE TICKER vs. Its Peers

Zacks Commentary

Amedysis Reports 1Q Prelim Earnings

Apr 26, 2013

Zacks Sell List Highlights: Brookdale Senior Living, Best Buy, Chemed and E I Du Pont De Nemours

Dec 20, 2012

Report for CHE

May 21, 2013

More CHE Zacks Commentary

Financials

EPS TTM	5.23
Sales	1,430
Net Income	91
Price/Earnings	12.94
Price/Book	2.68
Price/Cash Flow	9.53
Price/Sales	0.90

More CHE Financials

News

Chemed Corp. Hosts Meeting of Shareholders; Board Declares Quarterly Dividend - Close-Up Media

May 23, 2013

Chemed Corporation to Present at the Deutsche Bank 38th Annual Health Care Conference - Businesswire

May 23, 2013

Chemed Holds Annual Meeting of Shareholders - Close-Up Media

May 23, 2013

Lifshitz Law Firm Announces Investigation of Chemed Corporation, Overhill Farms, Inc., Theragenics Corporation, and Websense, Inc. - Pr Newswire

May 22, 2013

Concord Medical Services Holdings is Among the Companies in the Health Care Services Industry With the Highest Forward Earnings Yield (CCM, GTIV, CHE) - Financial News Network Online - News Corner

May 21, 2013

Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend - Businesswire

May 20, 2013

Chemed Keeps Dividend Steady - TheMotleyFool

May 20, 2013

Law Offices of Todd M. Garber Announces Investigation of Chemed Corporation - Businesswire

May 20, 2013

See All News Stories on CHE

Broker Recommendations

Current ABR	2.40
ABR (Last Week)	2.40
# of recs in ABR	5
Average Target Price	74.75
Industry Rank by ABR	206 out of 265
Rank in Industry	12 out of 16

More CHE Broker Recommendations

Username: Password:

Remember me [?]

Forgot Password

New Member

Chemed Corp New: (NYSE: CHE)

$67.73

0.04 (0.06%)

Volume 124,470

May 23 04:04 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED-OUTP/HM CRE

Zacks Commentary

Amedysis Reports 1Q Prelim Earnings

Zacks Sell List Highlights: Brookdale Senior Living, Best Buy, Chemed and E I Du Pont De Nemours

Report for CHE

Financials

News

Chemed Corp. Hosts Meeting of Shareholders; Board Declares Quarterly Dividend - Close-Up Media

Chemed Corporation to Present at the Deutsche Bank 38th Annual Health Care Conference - Businesswire

Chemed Holds Annual Meeting of Shareholders - Close-Up Media

Lifshitz Law Firm Announces Investigation of Chemed Corporation, Overhill Farms, Inc., Theragenics Corporation, and Websense, Inc. - Pr Newswire

Concord Medical Services Holdings is Among the Companies in the Health Care Services Industry With the Highest Forward Earnings Yield (CCM, GTIV, CHE) - Financial News Network Online - News Corner

Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend - Businesswire

Chemed Keeps Dividend Steady - TheMotleyFool

Law Offices of Todd M. Garber Announces Investigation of Chemed Corporation - Businesswire

Broker Recommendations

Day Low - High	67.07 - 68.10
52wk Low - High	54.06 - 82.00
Previous Close	67.69
Avg. Volume	551,234
Industry	MED-OUTP/HM CRE
Market Cap	1.30 B
Div - Yield	0.72 - 1.06
Beta	0.42
PE (Forward)	13.70
Current Year Est.	4.94
Quarterly Earnings ESP	0.00%

PE (Forward)	13.70
PEG Ratio	1.10
Current Year Est.	4.94
Current Quarter Estimate	1.16
Most Accurate Estimate	1.16
Earnings ESP	0.00%
Next Earnings Report Date	07-24-2013
EPS Last Year	5.23
Expected Earnings Growth	12.50%